查询词典 placebo

Apr 23, 2002 -- Chronic daily headaches of migraine, migrainous, or tension type responded to tizanidine in a double-blind, placebo-controlled trial reported at the American Academy of Neurology annual meeting in Denver, Colorado.

2002年4月23日─在美国科罗拉多州多佛举行的美国神经病学研究院年会上报导的一次双盲安慰剂对照试验的结果显示，采用治疗包括偏头风、偏头痛以及紧张性头痛在内的慢性经常性头痛(Chronic daily headaches， CDH)有效。

"Tizanidine showed superior efficacy over placebo for chronic daily headache (migraine, migrainous, and chronic tension-type headache)," the authors write.

作者写道：「Tizanidine治疗慢性经常性头痛（偏头风，偏头痛与慢性紧张性头痛），效果优于镇定剂。

Methods: This randomized, double-blind, placebo-controlled multicenter trial assessed the efficacy and tolerability of adjunctive treatment with levetiracetam 3,000 mg/day in adolescents (12 years) and adults (65 years) with idiopathic generalized epilepsy, who experienced myoclonic seizures on 8 days during a prospective 8-week baseline period, despite antiepileptic monotherapy.

本研究采用随机、双盲、安慰剂对照的多中心研究方式，评价在患有特发性全身性癫痫，虽抗癫痫治疗，仍在治疗后的8星期基线期内有8天为肌阵挛性发作的青少年（12岁）和成年（65岁）中使用左乙拉西坦3000mg/天作为辅助治疗的效果和耐受性。

The scores of neuropsychiatric side effects were lower in neurostan group as compared with placebo group during the treatment.

精神量表评分在治疗组的治疗过程中无明显变化，安慰剂组的量表评分显著高于治疗前和治疗组。

Teriparatide reduced the risk of any new, new adjacent, and new nonadjacent vertebral fractures by 72%, 75%, and 70%, respectively, compared with the rates in the placebo group.

与安慰剂组对比，特立帕肽降低新鲜骨折、新鲜邻近椎体骨折、新鲜非邻近椎体骨折发生率分别为72%， 75%， 70%，而雷洛昔芬分别为54%， 54%， and 53%。

Methods: Data from the Fracture Prevention Trial and the Multiple Outcomes of Raloxifene Evaluation trial were analyzed to determine the incidences of new adjacent and new nonadjacent vertebral fractures in the placebo groups and the effect of treatment with raloxifene and teriparatide on the incidence of new adjacent vertebral fractures as compared with that of new nonadjacent vertebral fractures.

研究数据来自于骨折防预试验中心，比较雷洛昔芬与安慰剂组对椎体骨折后再发生邻近椎体骨折及非邻近椎体骨折的发生率以及应用特立帕肽、雷洛昔芬对椎体骨折后再发生邻近椎体骨折及非邻近椎体骨折的风险情况。

Results: Among the 1699 subjects included in the efficacy analysis, NXY-059 significantly improved the overall distribution of scores on the modified Rankin scale, as compared with placebo （P = 0.038 by the Cochran-Mantel-Haenszel test）. The common odds ratio for improvement across all categories of the scale was 1.20 （95 percent confidence interval, 1.01 to 1.42）. Mortality and rates of serious and nonserious adverse events were each similar in the two groups.

结果：在1699例可进行有效分析的患者中，NXY-059较安慰剂显著改善了患者改良Rankin量表评分的总体分布（CMH检验P=0.038），量表所有项目的评分都得到改善的共同OR值为1.20（95％CI1.01～1.42），两组患者的死亡率及严重和不严重副作用的发生率均相似。

Main outcome measures The use of 21 classes of prescription medication was compared in the hormone therapy arms and placebo or nontreatment trial arms.

主要结果测量方法：比较该试验激素替代治疗组（2个亚组）、安慰剂组和非治疗组21类处方药的使用情况。

Design Follow up of a randomised controlled trial with a blind subtrial of hormone therapy versus placebo and a nonblind subtrial of open label hormone therapy versus nontreatment.

设计：随机对照试验设计：亚组盲法激素替代治疗 vs安慰剂治疗和亚组非盲法激素替代治疗 vs非治疗，并随访。

Design Follow up of a randomised controlled trial with a blind subtrial of hormone therapy ersus placebo and a nonblind subtrial of open label hormone therapy ersus nontreatment.

设计：随机对照试验设计：亚组盲法激素替代治疗 s安慰剂治疗和亚组非盲法激素替代治疗 s非治疗，并随访。

Breath, muscle contraction of the buttocks; arch body, as far as possible to hold his head, right leg straight towards the ceiling (peg-leg knee in order to avoid muscle tension).

呼气，收缩臀部肌肉；拱起身体，尽量抬起头来，右腿伸直朝向天花板（膝微屈，以避免肌肉紧张）。

The cost of moving grain food products was unchanged from May, but year over year are up 8%.

粮食产品的运输费用与5月份相比没有变化，但却比去年同期高8％。